Metastatic Bone Pain Palliation using 177 Lu-Ethylenediaminetetramethylene Phosphonic Acid

Metastatic Bone Pain Palliation using 177 Lu-Ethylenediaminetetramethylene Phosphonic Acid

177 Lu-ethylenediaminetetramethylene phosphonic acid (EDTMP) is presently suggested as an excellent bone seeking radionuclide for developing metastatic bone pain (MBP) palliation agent owing to its suitable nuclear decay characteristics. To find the exact dosage and its efficiency, this clinical stu...

Full description

Bibliographic Details
Main Authors: Mehrosadat Alavi, Shapour Omidvari, Alireza Mehdizadeh, Amir R Jalilian, Ali Bahrami-Samani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:World Journal of Nuclear Medicine
Subjects:
177 Lu-ethylenediaminetetramethylene phosphonic acid
bone pain palliation
metastasis
nuclear medicine
targeted radionuclide therapy
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2015;volume=14;issue=2;spage=109;epage=115;aulast=Alavi

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2015;volume=14;issue=2;spage=109;epage=115;aulast=Alavi

Similar Items